Literature DB >> 17884616

Conduits for hemodialysis access.

Eric C Scott1, Marc H Glickman.   

Abstract

The role of prosthetic arteriovenous (AV) access is still important in the management and care of the renal dialysis patients. Multiple new modalities are available to the surgeon today and it is imperative that their role be understood so that optimum care can be delivered to this complex group of patients. This article describes significant changes in prosthetic management and newer configurations available to the surgeon.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17884616     DOI： 10.1053/j.semvascsurg.2007.07.007

Source DB:  PubMed          Journal:  Semin Vasc Surg        ISSN： 0895-7967            Impact factor:   1.000


  5 in total

1.  Intima/medulla reconstruction and vascular contraction-relaxation recovery for acellular small diameter vessels prepared by hyperosmotic electrolyte solution treatment.

Authors:  Shunsuke Sakakibara; Yasuhisa Ishida; Kazunobu Hashikawa; Tetsuji Yamaoka; Hiroto Terashi
Journal:  J Artif Organs       Date:  2014-02-22       Impact factor: 1.731

2.  The longevity of arteriovenous graft for hemodialysis patients--externally supported or nonsupported.

Authors:  Yen-Ni Hung; Po-Jen Ko; Yee-Yung Ng; Shiao-Chi Wu
Journal:  Clin J Am Soc Nephrol       Date:  2010-04-08       Impact factor: 8.237

Review 3.  Lower Extremity Permanent Dialysis Vascular Access.

Authors:  Vishal B Parekh; Vandana D Niyyar; Tushar J Vachharajani
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-27       Impact factor: 8.237

4.  Personalized tissue-engineered arteries as vascular graft transplants: A safety study in sheep.

Authors:  Lachmi Jenndahl; Klas Österberg; Yalda Bogestål; Robin Simsa; Tobias Gustafsson-Hedberg; Patrik Stenlund; Sarunas Petronis; Annika Krona; Per Fogelstrand; Raimund Strehl; Joakim Håkansson
Journal:  Regen Ther       Date:  2022-09-07       Impact factor: 3.651

5.  The Tissue-Engineered Vascular Graft-Past, Present, and Future.

Authors:  Samand Pashneh-Tala; Sheila MacNeil; Frederik Claeyssens
Journal:  Tissue Eng Part B Rev       Date:  2015-10-08       Impact factor: 6.389
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.